AVTR+19.50%12.5%
CDMO0.00%12.5%
CERT-15.95%12.5%
CRL+73.43%12.5%
CYRX+74.29%12.5%
FTRE+189.51%12.5%
NOTV0.00%12.5%
TKNO+28.97%12.5%
As of Aug 6, 2026, 4:25 AM ET
MedTech Long '25 : US Drug Dev Outsourcing Constituents
Alpha Teknova, Inc.TKNO | 12.5% | 1.63% | 12.88% | 1.45% | 12.20% | 47.63% | 117.44% | 2.75% | 28.97% | $300.8M |
Avantor, Inc.AVTR | 12.5% | -2.34% | 16.78% | 28.83% | -3.05% | 16.58% | 47.62% | -17.99% | 19.50% | $9.12B |
Avid Bioservices, Inc.CDMO | 12.5% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $361.4M |
Certara, Inc.CERT | 12.5% | 2.69% | 6.66% | 12.34% | -1.11% | -9.08% | 13.14% | -21.70% | -15.95% | $1.25B |
Charles River Laboratories International, Inc.CRL | 12.5% | 11.36% | 15.07% | 12.66% | 12.13% | 30.70% | 46.07% | 74.65% | 73.43% | $12.56B |
Cryoport, Inc.CYRX | 12.5% | 0.20% | -0.78% | 0.13% | 1.06% | 58.85% | 81.12% | 147.56% | 74.29% | $768.6M |
Fortrea Holdings Inc.FTRE | 12.5% | 5.89% | -2.41% | 6.72% | -0.63% | 10.43% | 77.71% | 153.66% | 189.51% | $1.80B |
Inotiv, Inc.NOTV | 12.5% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $553.0M |
| Theme return | — | 2.43% | 6.03% | 8.33% | 2.73% | 24.50% | 49.04% | 50.09% | 52.97% | — |
| Average | 12.5% | 2.43% | 6.03% | 7.77% | 2.58% | 19.39% | 47.89% | 42.37% | 46.22% | $3.34B |
| Median | 12.5% | 0.91% | 3.33% | 4.09% | 0.00% | 13.51% | 46.85% | 1.38% | 24.24% | $1.01B |
| Std Dev | 0.0% | 4.06% | 7.37% | 9.41% | 5.65% | 22.73% | 39.73% | 68.37% | 62.46% | $4.44B |
| Min | 12.5% | -2.34% | -2.41% | 0.00% | -3.05% | -9.08% | 0.00% | -21.70% | -15.95% | $300.8M |
| Max | 12.5% | 11.36% | 16.78% | 28.83% | 12.20% | 58.85% | 117.44% | 153.66% | 189.51% | $12.56B |
| % Positive Tickers | 62.50% | 50.00% | 75.00% | 37.50% | 62.50% | 75.00% | 50.00% | 62.50% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
MedTech Long '25 : US Drug Dev Outsourcing tracks 8 publicly listed stocks in this theme: AVTR, CDMO, CERT, CRL, CYRX, FTRE, NOTV, TKNO. See the constituent table for details.